CRISPR-Cas systems are prokaryotic immune systems that confer resistance to foreign genetic elements such as plasmids and phages. CRISPR-Cas systems have been exploited for targeted genome editing.
A high-level overview of Simplify China A Shares PLUS Income ETF (CAS). Stay up to date on the latest price, chart, news, analysis, fundamentals, trading and investment tools.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results